Authors:
Chinetti, G
Lestavel, S
Bocher, V
Remaley, AT
Neve, B
Torra, IP
Teissier, E
Minnich, A
Jaye, M
Duverger, N
Brewer, HB
Fruchart, JC
Clavey, V
Staels, B
Citation: G. Chinetti et al., PPAR-alpha and PPAR-gamma activators induce cholesterol removal from humanmacrophage foam cells through stimulation of the ABCA1 pathway, NAT MED, 7(1), 2001, pp. 53-58
Authors:
Torra, IP
Chinetti, G
Duval, C
Fruchart, JC
Staels, B
Citation: Ip. Torra et al., Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice, CURR OP LIP, 12(3), 2001, pp. 245-254
Authors:
Lacquemant, C
Lepretre, F
Torra, IP
Manraj, M
Charpentier, G
Ruiz, J
Staels, B
Froguel, P
Citation: C. Lacquemant et al., Mutation screening of the PPAR alpha gene in type 2 diabetes associated with coronary heart disease, DIABETE MET, 26(5), 2000, pp. 393-401
Authors:
Flavell, DM
Torra, IP
Jamshidi, Y
Evans, D
Diamond, JR
Elkeles, RS
Bujac, SR
Miller, G
Talmud, PJ
Staels, B
Humphries, SE
Citation: Dm. Flavell et al., Variation in the PPAR alpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects, DIABETOLOG, 43(5), 2000, pp. 673-680
Citation: Ip. Torra et al., Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging, CURR OP LIP, 10(2), 1999, pp. 151-159
Authors:
Gervois, P
Torra, IP
Chinetti, G
Grotzinger, T
Dubois, G
Fruchart, JC
Fruchart-Najib, J
Leitersdorf, E
Staels, B
Citation: P. Gervois et al., A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity, MOL ENDOCR, 13(9), 1999, pp. 1535-1549